Goals of the Virtual Forums
Objectives of the Virtual Forums included:
- Identify gaps and opportunities in the basic understanding of tumor-draining lymph node (tdLN) biology and immunology that are critical for empowering clinical decision-making.
- Enable scientists to address clinically relevant questions and translate mechanistic insights into actionable strategies.
- Foster collaborations between clinicians and basic researchers, including identifying opportunities for access to patient samples, ensuring their optimal and efficient use by biologists, and aligning sample acquisition with the most pressing scientific questions.
Recordings of Past Virtual Forums
Tuesday, January 13, 2026
Lymph Nodes Remodeling in Health and Disease: Lessons for Cancer
Moderator & Speakers:
- Burkhard Ludewig, D.V.M., Professor, Cantonal Hospital St. Gallen
- Amanda W. Lund, Ph.D., Associate Professor, NYU Grossman School of Medicine
- Ivan Maillard, M.D., Ph.D., Head of the Division of Hematologic Malignancies, MSKCC
- Sophie E. Acton, Ph.D., Professor of Immunology, University College London
Thursday, February 12, 2026
Events that Facilitate Metastasis to the Tumor Draining Lymph Nodes
Moderator & Speakers:
- Timothy P. Padera, Ph.D., Professor of Radiation Oncology, Massachusetts General Hospital and Harvard Medical School
- Jessalyn M. Ubellacker, M.D., Ph.D., Assistant Professor, Department of Molecular Metabolism, Harvard T.H. Chan School of Public Health
- Stefani Spranger, Ph.D., Associate Director of Koch Institute for Integrative Cancer Research and Kathleen and Curtis; Marble Professor in Cancer Research, Massachusetts Institute of Technology
- Jonathan Villena-Vargas, M.D., Assistant Professor of Cardiothoracic Surgery, New York-Presbyterian/Weill Cornell Medical Center
Tuesday, March 10, 2026
Moderator & Speakers:
- Nathan Reticker-Flynn, Ph.D., Assistant Professor, Stanford University
- Mary Jo Turk, Ph.D., Professor, Dartmouth Geisel School of Medicine
- Kamila Naxerova, Ph.D., Associate Professor, Harvard Medical School
- Alexander Huang, M.D., Assistant Professor, Perelman School of Medicine at the University of Pennsylvania
Thursday, April 23, 2026
Moderator & Speakers:
- Tanja D. De Gruijl, Ph.D., Professor of Translational Immunology, Amsterdam UMC
- Eliane Piaggio, Ph.D., Translational Immunotherapy Team, Institut Curie
- Nicolas Girard, M.D., Ph.D., Thoracic Oncologist, Institut Curie
- Sylvio Gutkind, Ph.D., Distinguished Professor and Chair, Department of Pharmacology, UCSD Moores Cancer Center
Tuesday, May 12, 2026
Tumor Draining Lymph Nodes in the Context of Tertiary Lymphoid Structures
Moderator & Speakers:
- Marie-Caroline Dieu-Nosjean, Ph.D., Research Director, Center of Immunology and Microbial Infections (Cimi), Inserm, Sorbonne University
- Francesca Barone, M.D., Ph.D., Chief Scientific Officer, Candel Therapeutics
- Nikhil S Joshi, Ph.D., Associate Professor of Immunobiology, Co-Leader for Cancer Immunology Program, Yale School of Medicine
- Juan C. Osorio, M.D., Assistant Member, Immuno-Oncology Program, Department of Medicine, Memorial Sloan Kettering Cancer Center
Thursday, June 18, 2026
Emerging Technologies and Models to Study Human Lymph Node Metastasis: Challenges and Opportunities
Moderator & Speakers:
- Matthew H. Spitzer, Ph.D., Associate Professor, University of California, San Francisco and the Gladstone Institutes
- Benjamin Kahn, Ph.D., Medical Student, University of Pennsylvania
- Ang Cui, Ph.D., Assistant Professor, Brigham and Women's Hospital/Harvard Medical School and Broad Institute
- Sri Krishna, Ph.D., Stadtman Investigator, Surgery Branch, NCI
- Susan N. Thomas, Ph.D., Woodruff Professorship and Full Professor, Georgia Institute of Technology
DCB Contacts for the TDLN Virtual Forums
For additional information about the TDLN Virtual Forum Series, please contact Dr. Monica Zamisch or Dr. Christine Nadeau.